In Vitro studies have shown promise against viruses similar to the bird flu virus BOSTON, MASSACHUSETTS, March 19, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical ...
In Vitro studies have shown promise against viruses similar to the bird flu virus BOSTON, MASSACHUSETTS, March 19, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the "Company"), a clinical st ...
The clinical-stage biopharmaceutical firm is pushing its NMDA platform while building a national network of psychiatric ...
The recruitment for the Genshin Impact version 5.6 Closed Beta Test has started and interested players can sign up for it ...
Robert Reid, the FIA's deputy president for sport, and David Richards, the UK's representative, were among those denied access after refusing to sign a non-disclosure agreement (NDA). The document ...
Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, announced the execution of a five-year ...
Based on the feedback from the FDA, the Company’s regulatory data package would be sufficient for the submission of an sNDA for AXS-05 for the treatment of Alzheimer’s disease agitation. Axsome ...
“Generative AI is redefining document processing by transforming unstructured data into actionable insights at scale,” says ...
Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, announced the execution of a five-year strategic supply and development (“SSD”) agreement for TRIESENCE ...
Fast Company's annual list of the World's Most Innovative Companies spotlights organizations across various industries that are driving meaningful change through groundbreaking ideas and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback